COURTESY OF LIBRARY OF CONGRESS, PRINTS AND PHOTOGRAPHS DIVISION Bush's isn't the only administration to use science selectively. Here's a sampling of previous incidents: Truman Subjected almost 60,000 federal scientists and those with access to classified information to security reviews, costing some clearances and work. Nixon Dissolved the office of the presidential science advisor. Asked candidate to head Nat

Is the 43rd President of the United States really science's worst-ever enemy? By Alison McCook ARTICLE EXTRAS Related Articles: Enemies of the State Bush's isn't the only administration to use science selectively. Here's a sampling of previous incidents. Science and the President Is Bush science's nemesis? Or are we being unreasonably rough on his record? Let's get Political: President Bush has done his fair share of interfering

Deputy director John Niederhuber given permanent position at cancer funding agency

During one of the most linkurl:memorable;http://www.the-scientist.com/blog/display/23254/ conference sessions I attended, a researcher from Japan wowed an entire Keystone meeting on stem cells by announcing he had found a way to reprogram adult stem cells into embryonic stem cells using only a few factors. What those factors were, however, Shinya Yamanaka from Kyoto University wouldn?t say -- even after numerous probing questions from the audience. Now, Yamanaka is revealing his secrets in the

FEATUREThe Inequality of Science   © JOELLE BOLTIn 2004, close to one in five extramural NIH dollars went to only 10 of the 3,000 institutions that received grants. Five US states get almost half of all funding. What about everyone else? BY ALISON MCCOOKThe ceiling in the medical school at the University of South Dakota (USD) in Vermillion is visibly water-stained and falling down in spots. Walking through the fac

FEATUREThe Inequality of Science   How to get to the topPrincipal investigators on last year's list of the 20 biggest grants offer advice about how to get where they are. BY ALISON MCCOOK1. Experiment with your experimentsOne of the keys to scientific success for Lawrence Corey at the University of Washington in Seattle was doing different things at different times in his career, then finding a way to marry the experiences

FDA plans to review guidelines, while new report shows conflicts common in NAS panels

In a largely symbolic victory for biomedical research, the Senate today (July 18) approved a linkurl:controversial bill;http://www.the-scientist.com/news/display/23895/ (HR 810) to extend Federal research funding to newly derived human embryonic stem cells (hESC). The legislation faces a veto from President Bush, who opposes the expansion of funding on ethical grounds. Indeed, on Monday (July 17) the White House reaffirmed the president?s intention to veto the bill. After 12 hours of discussi

?It?s how we describe the thing that almost makes more of a difference than what it is.? These words, from linkurl:Patricia Alt;http://wwwnew.towson.edu/healthscience/alt.html of Towson University in Maryland, are particularly applicable to hot button issues in bioethics, particularly the ever-raging debate over using embryos for stem cell research. At linkurl:this week?s;http://www.the-scientist.com/blog/display/23946/ conference on linkurl:Bioethics & Politics,;http://politics.bioethics.net/

The linkurl:Bioethics & Politics;http://politics.bioethics.net/ conference hosted by the Albany Medical College got off to a bang today, not a whimper. As participants trickled in, networking and finding old friends, another, uninvited group calmly filed in, parked in front of the room, and started shouting at the tops of their lungs. The protesters, around 30 or so, were from linkurl:Not Dead Yet,;http://www.notdeadyet.org/ a disability rights group that is against legalized euthanasia and oth

People linkurl:love to complain;http://www.the-scientist.com/article/display/23061/ about peer review. (The system is too secretive, reviewers nix their competitors? papers, etc.) Still, very little ever changes in peer review, so the same complaints circulate for years with no noticeable effect. So when something potentially system-altering happens, it?s newsworthy. Last week, Nature performed such a service by introducing a linkurl:new feature;http://blogs.nature.com/nature/peerreview/trial/

Hwang Woo-suk, the South Korean researcher who admitted fabricating data on human stem cell lines, has been charged with criminal fraud and embezzlement, and now potentially faces years in jail, prosecutors announced Friday (May 12). In a linkurl:statement;http://news.yahoo.com/s/nm/20060512/sc_nm/korea_science_dc;_ylt=AoWnlxWJZt1f3kSQ6kx3JgoPLBIF;_ylu=X3oDMTA5aHJvMDdwBHNlYwN5bmNhdA-- provided to Reuters, prosecutor Lee In-kyu accused Hwang of being the lead actor in an elaborate plot to fabric